EDSA logo

Edesa Biotech, Inc.

EDSA
Healthcare|Biotechnology|CA
$2.14
+0.01 (+0.47%)
DCF Value
$2.00
Tangible Book / Share
$0.77
Cash / Share
$1.15
Next Earnings Report
Dec 11, 2026
EPS est. -$0.58
Financing Filings (last 12 months)
5
Shelf registrations / offering prospectuses — latest Aug 20, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (5)

Dec 2027
Est. completion
P2Non-Segmental Vitiligo (NSV)
A Study of EB06 Versus Placebo in Adults With Moderate to Severe Non-segmental Vitiligo
NCT07889492n=80
Jul 2028
Est. completion
P2Acute Respiratory Distress Syndrome (ARDS)
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
NCT06701656n=200
Jul 2028
Est. completion
P2Acute Respiratory Distress Syndrome (ARDS)
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
NCT06701682n=200
Jul 2028
Est. completion
P2Acute Respiratory Distress Syndrome (ARDS)
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
NCT06703073n=600
Jul 2028
Est. completion
P2Acute Respiratory Distress Syndrome (ARDS)
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
NCT06701669n=200

Recent Press Releases

Edesa Biotech to Present at Guggenheim Healthcare Innovation Conference
Nov 4, 2026 · GlobeNewsWire
Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo Study
Oct 15, 2026 · GlobeNewsWire
Edesa Biotech Announces Pricing of $25.0 Million Public Offering
Aug 19, 2026 · GlobeNewsWire
Edesa Biotech Announces Proposed Public Offering
Aug 19, 2026 · GlobeNewsWire
Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results
Aug 13, 2026 · GlobeNewsWire

SEC Filings (76)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 4, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Oct 23, 20268-KMaterial eventDocumentIndex
Oct 15, 20268-KMaterial eventDocumentIndex
Aug 26, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 25, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 25, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Aug 20, 20268-KMaterial eventDocumentIndex
Aug 20, 2026424B5Offering prospectusDocumentIndex
Aug 19, 2026424B5Offering prospectusDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Aug 13, 20268-KMaterial eventDocumentIndex
Jul 13, 2026EFFECTDocumentIndex
Jul 13, 2026424B3Offering prospectusDocumentIndex
Jul 2, 2026S-3Shelf registrationDocumentIndex
Jun 26, 2026DDocumentIndex
Jun 18, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 16, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 11, 20268-KMaterial eventDocumentIndex
Jun 5, 20268-KMaterial eventDocumentIndex
May 29, 2026S-8Employee stock planDocumentIndex
May 29, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 15, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 14, 202610-QQuarterly reportDocumentIndex
May 14, 20268-KMaterial eventDocumentIndex
Apr 3, 2026ARSAnnual report to holdersDocumentIndex
Apr 3, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 3, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 16, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 3, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 2, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Mar 2, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Feb 24, 20268-KMaterial eventDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 13, 202610-QQuarterly reportDocumentIndex
Feb 13, 20268-KMaterial eventDocumentIndex